Sufentanil
Dsuvia
Opioid Agonist
NADAC/unit
N/A
Active Shortage
2 Manufacturers
2 ANDAs
Sufentanil relieves moderate to severe pain by acting on opioid receptors in the brain.
Active Shortages
2022-05-03 Not currently manufactured, Hikma Pharmaceuticals USA, Inc.
2022-05-03 Not currently manufactured, Hikma Pharmaceuticals USA, Inc.
2022-05-03 Shortage reported, Hospira, Inc., a Pfizer Company
2022-05-03 Not currently manufactured, Hikma Pharmaceuticals USA, Inc.
Generic Manufacturers
HIKMA PHARMACEUTICALS USA INCHOSPIRA INCRISING PHARMA HOLDINGS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.